Cointime

Life Sciences Alternative Funding

investment firm

About

Life Sciences Alternative Funding provides capital to commercial-stage life sciences companies.

Highlights

Investments
4
Lead Investments
1
Exits
3
Employee Profiles
1

Details

Operating Status
Active
Investor Type
Venture Debt

Investments

Number of Investments
Number of Lead Investments
4
1
Life Sciences Alternative Funding has made 4 investments. Their most recent investment was on May 12, 2015, when Harrow Health raised $15M.
Date Company Name
Round Money Raised Industry Lead Investor
May 12, 2015 Harrow Health
Post-IPO Debt $15M Biotechnology —
Mar 10, 2015 Veniti
Debt Financing — Biotechnology Yes
Apr 29, 2014 Integrated Diagnostics
Debt Financing $17M Biotechnology —
Sep 17, 2013 VisionCare Ophthalmic Technologies
Debt Financing $15M Health Care —

Employee Profiles

Number of Employee Profiles
1
Life Sciences Alternative Funding has 1 current employee profiles, including Executive Steve DeNelsky
Steve DeNelsky
Executive

Exits

Life Sciences Alternative Funding has had 3 exits. Life Sciences Alternative Funding most notable exits include Veniti ,   Integrated Diagnostics

Date Company Name Exit Type Industry
Aug 8, 2018 Veniti M&A Biotechnology Detail
Jul 9, 2018 Integrated Diagnostics M&A Biotechnology Detail
Apr 30, 2007 Harrow Health IPO Biotechnology Detail
Cointime
Insight
Features
RSS
Company